Iaso Therapeutics Announces First Close in $1.25M Equity Series Seed Preferred Financing

/PRNewswire/ -- Iaso Therapeutics, a Michigan State University startup developing novel technologies for next-generation vaccines, recently closed the first...

Related Keywords

Michigan State University ,Michigan ,United States ,East Lansing ,Jeff Wesley ,Robert Forgey ,Xuefei Huang ,Don Parfet ,Jeremy Witt ,Seed Fund ,Institute For Quantitative Health Science Engineering ,Michigan Economic Development Corporation ,Michigan Venture Fund ,Apjohn Group ,Michigan Economic Development Corporation Emerging Technology Fund ,Michigan State University Research Foundation ,Michigan Small Business Development Center ,Department Of Chemistry ,Foundation Professor ,National Science Found Phase ,Iaso Therapeutics Inc ,Series Seed Preferred ,Michigan Rise Pre Seed ,Red Cedar Ventures Pre Seed Fund ,Emerging Technology Fund ,Iaso Therapeutics ,Michigan State ,Executive Director ,Managing Director ,Spartan Innovations ,Biomedical Engineering ,Quantitative Health Science ,Red Cedar Ventures ,Cedar Ventures ,Mid Michigan Venture Fund ,Michigan Rise ,Health Care Amp Hospitals ,Biotechnology ,Medical Pharmaceuticals ,Venture Capital ,Financing Agreements ,